Profile cover photo
Profile photo
Euretos
32 followers -
Answers to your research questions. Faster.
Answers to your research questions. Faster.

32 followers
About
Euretos's posts

Post has attachment

Post has attachment
Public
Novel gene promoting tumor metastasis points to new therapeutic approaches https://goo.gl/7OKX02

Post has attachment
Just a few days ago researchers discovered a new gene that is potentially involved in certain Tau protein related cognitive disorders like Alzheimer's disease. In this research note we outline which underlying genetic interactions and molecular mechanisms are likely involved. https://goo.gl/X4nSeI


Post has attachment
Novel target identification scoring model presented at the EMBL Target Validation Using Genomics and Informatics conference.

This innovative target validation approach from Euretos is shown to be highly effective in predicting potential drug targets.

https://goo.gl/MXCHLA

Post has attachment
Novel target identification scoring model presented at the EMBL Target Validation Using Genomics and Informatics conference.

This innovative target validation approach from Euretos is shown to be highly effective in predicting potential drug targets.

https://goo.gl/MXCHLA

Post has attachment
Novel target identification scoring model presented at the EMBL Target Validation Using Genomics and Informatics conference.

This innovative target validation approach from Euretos is shown to be highly effective in predicting potential drug targets.

https://goo.gl/MXCHLA


Post has attachment
Novel target identification scoring model presented at the EMBL Target Validation Using Genomics and Informatics conference.

This innovative target validation approach from Euretos is shown to be highly effective in predicting potential drug targets.

https://goo.gl/MXCHLA


Post has attachment
Public

Euretos presents groundbreaking drug target validation approach at EMBL conference

Euretos has been selected to speak at the Target Validation Using Genomics and Informatics conference from 4-6 December, organised by EMBL, Europe’s flagship laboratory for the life sciences.The topic of the Euretos presentation will be the groundbreaking work on target discovery which Euretos also presented on at the ECCB in September of this year. In particular the Euretos Target Identification application will be presented. The conference brings together a balanced mix of academic researchers, pharma & biotech scientists and technology providers.

The ability to guide researchers to discover novel therapeutic targets or biomarkers is regularly confirmed through recent scientific discoveries in various disease areas, such as: breast cancer, pancreatic cancer, chronic kidney disease and traumatic brain injury.

“We are very honoured to have been selected to present at this prestigious event organised by EMBL”, says Aram Krol, Head of Product Management at Euretos. “It is an especially interesting event as academic and industry partners are equally represented. We have strong evidence that our target identification scoring model is highly effective in predicting suitable drug targets and will be presenting especially on the progress we have made in this area”.

https://goo.gl/MXCHLA

Post has attachment
Public
We have just launched a new, groundbreaking application, Indication Expansion, that finds novel disease indications for existing drug targets. The area of ‘drug repurposing’ is one of the key growth areas in pharma & biotech. Tomorrow we will publish a recently announced case where we prove that our predictions work. Stay tuned!

Post has attachment
Euretos Knowledge Platform expands coverage to become the broadest and fastest-growing life sciences knowledge base

We have made some truly exciting  progress in the ability of the Euretos Knowledge Platform to integrate new public sources. We are now at 65 public sources and will grow to 100 in the coming few months. In the article you can find out more.
Wait while more posts are being loaded